Skip to main content
. 2016 Feb 19;4:4. doi: 10.1186/s40364-016-0058-3

Fig. 2.

Fig. 2

Forest plot indicating the performance of the ESLA-7, CIN25 [17] and CPP [13] signatures in the seven early stage lung adenocarcinoma cohorts and in the TCGA LUAD validation cohort